A. Haller Julia's Insider Trades & SAST Disclosures
A. Haller Julia's most recent trade in Bristol-Myers Squibb Co. was a trade of 3,562 Deferred Share Units done . Disclosure was reported to the exchange on Feb. 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern A. Haller Julia.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 3,562 | 32,223 | - | - | Deferred Share Units | |
| Outlook Therapeutics Inc | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 56,636 | 56,636 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 47,232 | 47,232 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 12,082 | 12,082 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 94,441 | 94,441 | - | - | Stock Option (Right to Buy) | |
| Bristol-Myers Squibb Co. | Julia Haller A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 4,314 | 27,341 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | A. Haller Julia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 706 | 22,746 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2023 | 624 | 21,797 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 553 | 20,978 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 486 | 20,255 | - | - | Deferred Share Units | |
| Outlook Therapeutics Inc | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 41,065 | 41,065 | - | - | Stock Option (Right to Buy) | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 2,807 | 19,768 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 469 | 16,826 | - | - | Deferred Share Units | |
| Outlook Therapeutics Inc | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2022 | 42,239 | 42,239 | - | - | Stock Option (Right to Buy) | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 474 | 16,244 | - | - | Deferred Share Units | |
| Outlook Therapeutics Inc | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 438 | 15,654 | - | - | Deferred Share Units | |
| Eyenovia Inc | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 30,769 | 30,769 | - | - | Stock Option (right to buy) | |
| Eyenovia Inc | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 22,222 | 30,408 (0%) | 0% | 0 | Common Stock, par value $.0001 | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2022 | 2,949 | 0 | - | - | Restricted Stock Units | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2022 | 2,949 | 13,619 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 462 | 15,107 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 3,067 | 14,645 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2021 | 521 | 11,482 | - | - | Deferred Share Units | |
| Eyenovia Inc | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2021 | 9,653 | 9,653 | - | - | Stock Option (right to buy) | |
| Eyenovia Inc | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2021 | 6,963 | 8,186 (0%) | 0% | 0 | Common Stock, par value $.0001 | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 549 | 10,870 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 487 | 10,247 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2021 | 902 | 0 | - | - | Restricted Stock Units | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2021 | 902 | 10,670 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2021 | 2,949 | 2,949 | - | - | Restricted Stock Units | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2021 | 2,949 | 9,768 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Eyenovia Inc | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 1,637 | 1,637 | - | - | Stock Option (right to buy) | |
| Eyenovia Inc | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 1,223 | 1,223 (0%) | 0% | 0 | Common Stock, par value $.0001 | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 514 | 9,689 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 3,054 | 9,174 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2020 | 523 | 6,072 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 539 | 5,507 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 528 | 4,930 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2020 | 903 | 902 | - | - | Restricted Stock Units | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2020 | 903 | 6,261 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2020 | 558 | 6,819 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2020 | 558 | 0 | - | - | Restricted Stock Units | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2020 | 2,949 | 5,358 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2020 | 2,949 | 5,898 | - | - | Restricted Stock Units | |
| Bristol-Myers Squibb Co. | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2020 | 515 | 4,369 | - | - | Deferred Share Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges